Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients. (Q53805523)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2016

Language	Label	Description	Also known as
English	Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients.	scientific article published in August 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

0 references

type 2 diabetes

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

Markus Büchler

9

object named as

Markus W Büchler

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

Peter P Nawroth

8

object named as

Peter P Nawroth

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

5

object named as

Felix Nickel

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

Beat Peter Müller-Stich

10

object named as

Beat P Müller-Stich

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

author name string

Adrian T Billeter

1

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

Jonas Senft

2

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

Daniel Gotthardt

3

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

Philipp Knefeli

4

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

Thilo Schulte

6

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

Lars Fischer

7

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

publication date

1 August 2016

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

Obesity Surgery

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

26

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

8

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

1867-1874

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Gastric bypass and banding equally improve insulin sensitivity and β cell function

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Gastric bypass leads to improvement of diabetic neuropathy independent of glucose normalization--results of a prospective cohort study (DiaSurg 1 study).

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Comparison of the long-term results of Roux-en-Y gastric bypass and sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis of randomized and nonrandomized trials

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Nitrosative stress but not glycemic parameters correlate with improved neuropathy in nonseverely obese diabetic patients after Roux-Y gastric bypass.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the longitudinal assessment of bariatric surgery (LABS) study

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Updated definitions of healthy ranges for serum alanine aminotransferase levels

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

How do we define cure of diabetes?

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Single-lobe living donor liver transplant in a morbidly obese cirrhotic patient preceded by laparoscopic sleeve gastrectomy

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Bariatric surgery and end-stage organ failure.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Antidiabetic efficacy of obesity surgery in Germany: a quality assurance nationwide survey

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-2006-Y

21 January 2018

Laparoscopic sleeve gastrectomy in morbidly obese patients with end-stage heart failure and left ventricular assist device: medium-term results

1 reference

https://pubmed.ncbi.nlm.nih.gov/26660688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adipocyte death, adipose tissue remodeling, and obesity complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/26660688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The physiology underlying Roux-en-Y gastric bypass: a status report

1 reference

https://pubmed.ncbi.nlm.nih.gov/26660688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26660688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/26660688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26660688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FXR is a molecular target for the effects of vertical sleeve gastrectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26660688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26660688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11695-015-2006-Y

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 May 2018

http://europepmc.org/abstract/MED/26660688

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53805523&oldid=2212297225"